It took serendipity and an old grade school connection but not much time for Detroit-based Trimaran Pharma Inc. to line up a heavyweight trio of experienced pharmaceutical executives to lead the company.
Previously, the three were on development teams at pharmaceutical companies that launched such huge drug successes as Prozac, Lunesta, Lyrica and ?Cymbalta.
In December, the Wayne State University board of governors approved a licensing agreement with company founder Aloke Dutta, a professor in the department of pharmaceutical sciences, to commercialize a class of drugs called triple reuptake inhibitors, which show promise in treating depression, post-traumatic stress syndrome and attention deficit hyperactivity disorder.
